Please provide your email address to receive an email when new articles are posted on . Patients with psoriasis taking methotrexate were 2.8 times more likely to develop nonmelanoma skin cancer than ...

New research reports that higher blood concentrations of methotrexate during cancer treatment are associated with brain changes and impaired executive function in survivors of pediatric leukemia.

Please provide your email address to receive an email when new articles are posted on . Low-dose methotrexate — the most commonly used drug for systemic rheumatic diseases — was associated with small ...

The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug ...

Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer JCOG0905 is a multicenter, open-label, multi-institutional, randomized trial ...

(Reuters) - The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to ...

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates Patients ...

The medication methotrexate has been used for decades as a treatment for cancer patients and has emerged as an effective treatment for conditions including arthritis, lupus and Crohn’s disease. It’s ...

image: Yin Ting Cheung, Ph.D., postdoctoral research associate and Kevin Krull, Ph.D., faculty member of the Epidemiology / Cancer Control Department at St. Jude Children's Research Hospital. view ...

The U.S. Food and Drug Administration said on Friday it is seeking new suppliers to ease shortages of methotrexate, one of the most commonly used cancer drugs, building on its push to shore up two ...